217 related articles for article (PubMed ID: 34604097)
21. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches.
Zayed DG; Ebrahim SM; Helmy MW; Khattab SN; Bahey-El-Din M; Fang JY; Elkhodairy KA; Elzoghby AO
J Nanobiotechnology; 2019 Jan; 17(1):7. PubMed ID: 30660179
[TBL] [Abstract][Full Text] [Related]
22. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Guo J; Zeng H; Chen Y
Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
[TBL] [Abstract][Full Text] [Related]
23. Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery.
Tang L; Li J; Zhao Q; Pan T; Zhong H; Wang W
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452113
[TBL] [Abstract][Full Text] [Related]
24. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
25. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy.
Liang H; Zou F; Liu Q; Wang B; Fu L; Liang X; Liu J; Liu Q
Int J Pharm; 2021 Apr; 599():120418. PubMed ID: 33647414
[TBL] [Abstract][Full Text] [Related]
26. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
Song B; Wu S; Li W; Chen D; Hu H
Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
[TBL] [Abstract][Full Text] [Related]
27. [Research progress on triptolide functionalized nanoparticulate drug delivery systems for tumor treatment].
Luo YY; Shi JF; Chen L; Li JX; Ma XY; Zhang JM; Geng FN
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4566-4572. PubMed ID: 31872649
[TBL] [Abstract][Full Text] [Related]
28. The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment.
Hou J; Sun X; Huang Y; Yang S; Liu J; Feng C; Ma J; Chen B
Curr Med Chem; 2020; 27(36):6112-6135. PubMed ID: 31419927
[TBL] [Abstract][Full Text] [Related]
29. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
30. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
31. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
32. Development of High-Drug-Loading Nanoparticles.
Liu Y; Yang G; Jin S; Xu L; Zhao CX
Chempluschem; 2020 Sep; 85(9):2143-2157. PubMed ID: 32864902
[TBL] [Abstract][Full Text] [Related]
33. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
[TBL] [Abstract][Full Text] [Related]
34. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
George A; Shah PA; Shrivastav PS
Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
[TBL] [Abstract][Full Text] [Related]
35. Stiffness-tuneable nanocarriers for controlled delivery of ASC-J9 into colorectal cancer cells.
Tomeh MA; Hadianamrei R; Sun W; Xu D; Brown S; Zhao X
J Colloid Interface Sci; 2021 Jul; 594():513-521. PubMed ID: 33774407
[TBL] [Abstract][Full Text] [Related]
36. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
Florek J; Caillard R; Kleitz F
Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
[TBL] [Abstract][Full Text] [Related]
38. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
[TBL] [Abstract][Full Text] [Related]
39. Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy.
Wu Q; Niu M; Chen X; Tan L; Fu C; Ren X; Ren J; Li L; Xu K; Zhong H; Meng X
Biomaterials; 2018 Apr; 162():132-143. PubMed ID: 29448141
[TBL] [Abstract][Full Text] [Related]
40. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
